title: Inhibition of p38-mitogen-activated protein kinase may protect from clozapine-induced agranulocytosis.
authors.forename: Stefan
authors.initials: S
authors.lastname: Loeffler
authors.forename: Karin
authors.initials: K
authors.lastname: Fehsel
authors.forename: Klaus
authors.initials: K
authors.lastname: Krieger
authors.forename: Uwe
authors.initials: U
authors.lastname: Henning
authors.forename: Ansgar
authors.initials: A
authors.lastname: Klimke
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced* / Q000517:prevention & control*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D019833:Genistein / Q000008:administration & dosage / Q000494:pharmacology; D016179:Granulocyte Colony-Stimulating Factor / Q000187:drug effects; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*; D017382:Reactive Oxygen Species / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy; D012702:Serotonin Antagonists / Q000009:adverse effects*; D048051:p38 Mitogen-Activated Protein Kinases
chemical_list: D000970:Antineoplastic Agents; D017382:Reactive Oxygen Species; D012702:Serotonin Antagonists; D016179:Granulocyte Colony-Stimulating Factor; D019833:Genistein; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D003024:Clozapine